Jennewein Biotechnologie

2019

05.02.2019

Jennewein Biotechnologie and Yili Group join forces in China for microbiome research and human milk oligosaccharides for the largest baby food market: Jennewein Biotechnologie GmbH, the global leader in the research and… read more

2018

08.10.2018		Jennewein Biotechnologie GmbH acquires Arthus Mineralsprings Bad Hönningen to build a new integrated fermentation and recovery plant for human milk oligosaccharides: Jennewein Biotechnologie GmbH announces that it has acquired the former… read more
19.09.2018	PR	Jennewein Biotechnologie develops new fermentation technology for human milk oligosaccharides and expands its product portfolio: Jennewein Biotechnologie GmbH announces the introduction of a total biosynthesis… read more
22.06.2018		Jennewein Biotechnologie is building a new R&D Center in Bonn: On the 15th June 2018 Jennewein Biotechnologie has signed a… read more
20.06.2018	PR	18th European Congress on Biotechnology: In this year the European Congress on Biotechnology celebrate the… read more
04.05.2018		First clinical trial of a blend of human milk oligosaccharides emulating the human profile of infant formula: Jennewein Biotechnologie GmbH announces its first clinical trial of an… read more
13.04.2018		Jennewein Biotechnologie at the Deutsche Biotechnologietage in Berlin: Since 2010  yearly take place the Deutsche Biotechnologietage. In this… read more
06.04.2018		Jennewein Biotechnologie is finalist for the NutraIngredients Award: This year will take place the 4th edition of the… read more

2017

20.11.2017		EU approval for 2′-fucosyllactose: The Jennewein Biotechnologie GmbH received a response from the European… read more
17.11.2017	PR	Forum for science journalists and scientists: The symposium Wissenswerte is a forum for german science journalists… read more
05.10.2017		Networking for students, postgraduate students and graduates: Since 1999 the Biotechnologische Studenteninitiative e.V. organizes every year the… read more
20.07.2017	PR	Supply Side West, Las Vegas: The show Supply Side West in Las Vegas, who will… read more
20.07.2017	PR	Scientific conference about human milk: From the 16.-21.07.2017 takes part in Lisbon the conference “Origins… read more
20.06.2017		Presence at the fairs in Asia: Human milk oligosaccharides are a future market, especially in the… read more
15.05.2017		Food Asia Pacific Summit: The Food Asia Pacific Summit in Singapore, who will take… read more
15.05.2017		China, a future market: The Health Ingredients China will take place from the 20.-22.06.2017… read more
26.04.2017	PR	50th ESPGHAN Annual Meeting: The 50th annual meeting of the ESPGHAN will take place… read more
25.04.2017	PR	Jennewein Biotechnologie at the Vitafoods Europe: The Vitafoods Europe takes place from the 09.-11.05.2017 in Geneva… read more
17.03.2017		Jennewein Biotechnologie at the Food Vision Asia: The Food Vision Asia will take place from the 25.-27.04.2017… read more
17.03.2017		Jennewein Biotechnologie is part of an EU-campaign: In the context of an image campaign from the European… read more
18.01.2017		Participation at the Food Vision London: The Food Vision London will take place from the 01.-03.03.2017.… read more

2016

27.05.2016		by w4l3XzY3: The Jennewein Biotechnologie GmbH produces rare func- tionals sugars based… read more
25.05.2016	PR	Structural Basis for Norovirus Inhibition by Human Milk Oligosaccharides: Human milk oligosaccharides are a major component of mothers milk,… read more

2015

22.12.2015	PR	US FDA GRAS status for 2′-Fucosyllactose produced by Jennewein Biotechnologie: Jennewein Biotechnologie’s conclusion that its 2’-Fucosyllactose is GRAS for use… read more
02.12.2015	PR	European Investment Bank (EIB) lends EUR 10 million to Jennewein Biotechnologie: Luxembourg, 2 December 2015. The European Investment Bank (EIB) and… read more
30.09.2015		NASPGHAN Annual Meeting 2015: NASPGHAN Annual Meeting 2015 NASPGHAN is the sole professional organization in… read more
21.07.2015		FASEB Conference: Origins and Benefits of Biologically Active Components in Human Milk: Origins and Benefits of Biologically Active Components in Human Milk The… read more
20.04.2015		ESPGHAN Annual Meeting 2015: ESPGHAN Annual Meeting 2015 The scientific programme of the ESPGHAN… read more
15.01.2015		Effects of 2′-Fucosyllactose on hippocampal long-term potentiation and learning capabilities: Publication of Abbott Nutrition on Cognitive Effects of Human Milk… read more

2014

15.12.2014		Toxicology & Safety : A 3-week pre-clinical study of the human milk oligosaccharide 2′-Fucosyllactose in farm piglets: Publication of Toxicology & Safety Study on 2′-Fucosyllactose One of… read more
30.10.2014	PR	Protection against Norovirus by Human-Milk-Oligosaccharides: Federal Ministry of Education and Research supports Development of Norovirus… read more

2013

28.05.2013

Extension of production capacities for human milk oligosaccharides: Jennewein Biotechnologie headquartered in the Technologiezentrum für Oberflächentechnik (TZO) in… read more

2012

03.12.2012	PR	L-Fucose: Environmentally friendly and cost effective production for active anti-aging ingredient: L-Fucose –Sweet Key to a Youthful Skin Environmentally friendly and… read more
01.11.2012		Distribution partnership between Opalbond and Jennewein Biotechnologie: Jennewein Biotechnologie cooperates with Opelbond in the commercialization of L-Fucose for the use… read more

2011

29.08.2011

PR

Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Oligosaccharides: Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Components Jennewein… read more

2009

07.09.2009	PR	Human Milk Oligosaccharides: Natural Protection against Infectious Diseases: Natural Protection against Infectious Diseases Human-Milk-Oligosaccharides: Biotechnological production of sugar with beneficial… read more
01.08.2009		Distribution partnership between IMPAG and Jennewein Biotechnologie: IMPAG Import GmbH and Jennewein Biotechnology GmbH sign exclusive distribution… read more
15.04.2009		Distribution partnership between Laserson and Jennewein Biotechnologie: Laserson S.A. and Jennewein Biotechnologie GmbH enter in an exclusive… read more